Methods of restoring cognitive ability using non-peptidic compounds
US8962677B2 · kind B2 · utility
0Cited by
75References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2007 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Sep 21, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of enhancing cognitive impairment in a patient wherein the cognitive impairment is due to ADDL neurotoxicity. The methods employ non-peptidic compounds having a molecular weight of less than 1000 and which can antagonize against formation of neurotoxic ADDLs from Aβ1-42 monomers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.